Tetrahydro-11-deoxycortisol

Tetrahydro-11-deoxycortisol (Tetrahydrodeoxycortisol) is an endogenous metabolite present in Urine that can be used for the research of 11 Beta Hydroxylase Deficiency[1][2].

Product Specifications

CAS Number

[68-60-0]

Product Name Alternative

Tetrahydrodeoxycortisol

UNSPSC

12352211

Target

Endogenous Metabolite

Related Pathways

Metabolic Enzyme/Protease

Applications

Metabolism-protein/nucleotide metabolism

Field of Research

Others

Purity

98.20

Solubility

DMF : ≥ 50 mg/mL|DMSO : 50 mg/mL (ultrasonic)

Smiles

C[C@]1(CC2)[C@](CC[C@@]1(C(CO)=O)O)([H])[C@@]3([H])[C@@]2([H])[C@](CC[C@@H](O)C4)(C)[C@]4([H])CC3

Molecular Formula

C21H34O4

Molecular Weight

350.49

References & Citations

[1]Burren CP, et al. CYP11 beta 1 (11-beta-hydroxylase) deficiency in congenital adrenal hyperplasia. J Paediatr Child Health. 1996 Oct;32 (5) :433-8. |[2]Lee N, et al. Endogenous toxic metabolites and implications in cancer therapy. Oncogene. 2020 Aug;39 (35) :5709-5720.